Garen G Bohlin - Net Worth and Insider Trading
Garen G Bohlin Net Worth
The estimated net worth of Garen G Bohlin is at least $2 Million dollars as of 2024-06-11. Garen G Bohlin is the Director of Collegium Pharmaceutical Inc and owns about 52,468 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $2 Million. Garen G Bohlin is also the Director of Karyopharm Therapeutics Inc and owns about 45,140 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $43,714. Details can be seen in Garen G Bohlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Garen G Bohlin has not made any transactions after 2024-05-14 and currently still holds the listed stock(s).
Transaction Summary of Garen G Bohlin
Garen G Bohlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Garen G Bohlin owns 5 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Collegium Pharmaceutical Inc (COLL) , and Tetraphase Pharmaceuticals Inc (TTPH) among others .
Click here to see the complete history of Garen G Bohlin’s form 4 insider trades.
Insider Ownership Summary of Garen G Bohlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2023-09-12 | director |
| COLL | Collegium Pharmaceutical Inc | 2024-05-14 | director |
| TTPH | Tetraphase Pharmaceuticals Inc | 2019-06-10 | director |
 | | 2014-10-21 | director |
| | 2009-01-02 | director |
Garen G Bohlin Latest Holdings Summary
Garen G Bohlin currently owns a total of 2 stocks. Among these stocks, Garen G Bohlin owns 52,468 shares of Collegium Pharmaceutical Inc (COLL) as of May 14, 2024, with a value of $2 Million and a weighting of 97.56%. Garen G Bohlin also owns 45,140 shares of Karyopharm Therapeutics Inc (KPTI) as of September 12, 2023, with a value of $43,714 and a weighting of 2.44%.
Latest Holdings of Garen G Bohlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2024-05-14 | 52,468 | 33.33 | 1,748,758 |
| KPTI | Karyopharm Therapeutics Inc | 2023-09-12 | 45,140 | 0.97 | 43,714 |
Holding Weightings of Garen G Bohlin
Garen G Bohlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Garen G Bohlin has made a total of 1 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 28,985 shares on May 14, 2024, which brought Garen G Bohlin around $936,216.
According to the SEC Form 4 filings, Garen G Bohlin has made a total of 2 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Karyopharm Therapeutics Inc is the acquisition of 41,140 shares on September 12, 2023, which cost Garen G Bohlin around $50,191.
Insider Trading History of Garen G Bohlin
- 1
Garen G Bohlin Trading Performance
GuruFocus tracks the stock performance after each of Garen G Bohlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Garen G Bohlin is -37.36%. GuruFocus also compares Garen G Bohlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Garen G Bohlin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Garen G Bohlin's insider trading performs compared to the benchmark.
Performance of Garen G Bohlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.49 | | | | | |
| Relative Return to S&P 500(%) | 4.41 | | | | | |
Garen G Bohlin Ownership Network
Garen G Bohlin Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Garen G Bohlin is the director of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & CFO & Treasurer Michael Mason , director & President and CEO Richard A. Paulson , and EVP & Chief Medical Officer Reshma Rangwala .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Garen G Bohlin made 1 insider transaction in Karyopharm Therapeutics Inc (KPTI) with a net purchase of 41,140. Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,222 shares made by Richard A. Paulson , a net sale of 66,943 shares made by Michael Mason , and a net sale of 47,442 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 1,742,394 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 1,742,394 shares. During the past 18 months, 2,148,732 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,107,592 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Garen G Bohlin Mailing Address
Above is the net worth, insider trading, and ownership report for Garen G Bohlin. You might contact Garen G Bohlin via mailing address: C/o Praecis Pharmaceuticals Inc, 830 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
